Discover how peripheral blood T-cell receptor repertoire profiling can predict immunotherapy success in advanced non-small cell lung cancer patients.
Discover how gene expression profiling is revolutionizing lung cancer treatment by predicting doxorubicin sensitivity, enabling personalized oncology approaches.
New targeted therapies are changing outcomes for older adults with EGFR-mutated non-small-cell lung cancer, offering new hope through precision medicine.
Discover how marine bacterium Streptomyces sp. GMY01 from deep-sea environments shows remarkable promise in fighting human lung cancer by triggering apoptosis.
Discover how the alkaloid fraction from Sphaeranthus amaranthoides shows remarkable promise against lung cancer cells through scientific research.
How genetic profiling and precision medicine are transforming treatment for stage IV non-small cell lung cancer